VIKING THERAPEUTICS INC's ticker is and the CUSIP is 92686J906. A total of 5 filers reported holding VIKING THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $160,000 | +15.9% | 200 | 0.0% | 0.04% | -40.5% |
| Q3 2019 | $138,000 | -16.9% | 200 | 0.0% | 0.07% | -64.6% |
| Q2 2019 | $166,000 | -32.0% | 200 | -18.4% | 0.21% | +78.6% |
| Q1 2019 | $244,000 | -61.4% | 245 | -99.7% | 0.12% | -15.8% |
| Q4 2018 | $632,000 | -32.8% | 72,600 | +13344.4% | 0.14% | +15.8% |
| Q3 2018 | $941,000 | -9.3% | 540 | -50.6% | 0.12% | -25.0% |
| Q2 2018 | $1,038,000 | – | 1,094 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 200 | $160,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 281 | $225,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 279,000 | $2,238,000 | 0.02% |
| SIMPLEX TRADING, LLC | 1,310 | $1,050,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |